Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Sponsor: Gan and Lee Pharmaceuticals, USA
Summary
This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.
Official title: A Trial to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR33 Compared With Insulin Degludec at Steady State in Participants With Type 1 Diabetes
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2025-10-13
Completion Date
2026-04-15
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
GZR-33
GZR33 is a long-acting basal insulin analogue
Locations (2)
Profil Institut
Neuss, Germany
Profil
Neuss, Germany